FDA moves to reverse policies of former commissioner Marty Makary

The Trump administration is actively rolling back decisions made under former FDA commissioner Marty Makary.

As the White House weighs a new nominee for the agency, officials have begun revisiting rulings that were put in place during Makary’s tenure.

The shift signals a broader effort to reshape the FDA’s regulatory approach ahead of the upcoming leadership change.